Table 1.
Study cohort | No. (T/C) | Gender | Age | Course (day) | Outcome | ||
---|---|---|---|---|---|---|---|
T | C | T | C | ||||
An [20] | 38/38 | 22/16 | 20/18 | 57.03 ± 7.33 | 56.23 ± 7.26 | 30 | ①④ |
Chen et al. [21] | 52/52 | 30/22 | 29/23 | 49.6 ± 3.3 | 49.1 ± 3.6 | 21 | ①②④ |
Gao and Zhang [22] | 75/75 | 30/45 | 33/42 | 66.5 ± 11.3 | 69.5 ± 12.0 | 30 | ①②④ |
Huang [23] | 20/20 | 13/7 | 13/7 | 64.80 ± 7.08 | 65.30 ± 6.89 | 60 | ①②⑤⑥⑦ |
Lai et al. [24] | 34/34 | 18/16 | 23/11 | 58.2 ± 5.8 | 62.1 ± 6.9 | 56 | ①②⑤ |
Li [25] | 36/34 | 17/19 | 15/19 | — | — | 56 | ①②⑦ |
Liu and Yang [26] | 48/47 | 26/22 | 26/21 | 48.35 ± 6.24 | 48.35 ± 6.24 | 63 | ①②④⑦ |
Liu et al. [14] | 28/32 | 13/15 | 15/17 | 65.4 ± 8.7 | 63.7 ± 9.3 | 28 | ②④⑤ |
Wang and Li [27] | 49/49 | 36/13 | 35/14 | 59.63 ± 5.27 | 60.05 ± 5.69 | 28 | ①②③⑦ |
Wu [28] | 42/42 | 23/19 | 21/21 | 59.78 ± 7.82 | 60.54 ± 8.04 | 90 | ①②⑥ |
Zhao et al. [15] | 35/35 | 20/15 | 21/14 | 60.4 ± 4.5 | 60.5 ± 4.3 | 28 | ①②④⑤⑦ |
Zhu [29] | 38/38 | 24/14 | 26/12 | 46.34 ± 10.97 | 45.28 ± 11.26 | 42 | ①②③ |
Zhang et al. [30] | 68/66 | 29/39 | 19/47 | 65.91 ± 10.442 | 68.12 ± 9.731 | 14 | ①②④⑤ |
Note: ①, efficiency; ②, HAMD; ③, MESSS; ④, NIHSSS; ⑤, Barthel; ⑥, CSS; ⑦, adverse reactions rate; —, unclear.